BMS at the 62nd ASH Annual Meeting and Exposition

Critical research driving progress for people with blood cancers

Intended for scientific audiences only.
T

he American Society of Hematology Annual Meeting and Exposition (ASH) is the premier event in malignant and non-malignant hematology, and despite this year’s challenges, we remain ever-committed to sharing the latest advances and providing continued support as we continue to navigate the COVID-19 pandemic. We look forward to highlighting the depth and diversity of our hematology development program and potential new advances for people living with a range of blood cancers.

Our Commitment in Hematology

Hear from our Executive Vice President and President of Hematology, Nadim Ahmed, 博彩app软件下载app软件 the ways we’re working together in the current environment to improve survival outcomes for people with blood cancers.

Our Data at ASH

Read more 博彩app软件下载app软件 our key data being presented at ASH.

Our Science   

We are working every day to advance blood cancer treatments that have transformational potential. Learn 博彩app软件下载app软件 our recent advances and what we have on the horizon.

Building on Today’s Science to Research Medicines of Tomorrow
Building on Today’s Science to Research Medicines of Tomorrow

As a scientific research community, our work for people living with cancer is never done. Read 博彩app软件下载app软件 two examples of the research 博彩app软件下载app软件下载 Myers 博彩app软件下载 is elevating to advance next-generation approaches in oncology and hematology.

Advancing Acute Myeloid Leukemia Research Through Epigenetics
Advancing Acute Myeloid Leukemia Research Through Epigenetics

Instead of killing the cell, hypomethylating agents, or HMAs, alter the signaling process by re-expressing genes to work properly again. Learn more 博彩app软件下载app软件 the treatment of AML through epigenetics.

Protein Homeostasis 101: A Q&A With Josh Hansen
Protein Homeostasis 101: A Q&A With Josh Hansen

Years before Josh Hansen, director of chemistry at 博彩app软件下载app软件下载 Myers 博彩app软件下载’s San Diego R&D site,  found his calling in biopharma researching protein degradation, he had his sights set on a career in education. Read more 博彩app软件下载app软件 the important science being done in Josh’s lab.

Our Commitment   

We are committed to improving the lives of patients and raising awareness of hard-to-treat blood cancers. Learn more here.

Raising Awareness 博彩app软件下载app软件 Blood Cancers: A Diverse and Complex Group of Diseases
Raising Awareness 博彩app软件下载app软件 Blood Cancers: A Diverse and Complex Group of Diseases

Learn how 博彩app软件下载app软件下载 Myers 博彩app软件下载, in collaboration with advocacy partners, is committed to providing education, resources and support to people with blood cancers.

Addressing Barriers to Clinical Trial Participation and Clinical Trial Diversity During COVID-19 and Beyond
Addressing Barriers to Clinical Trial Participation and Clinical Trial Diversity During COVID-19 and Beyond

Hear from Chief Medical Officer Samit Hirawat, M.D., on how 博彩app软件下载app软件下载 Myers 博彩app软件下载 has helped patients overcome barriers to clinical trial participation and advanced its R&D pipeline during the global pandemic.

The Expanding Prevalence of Beta-thalassemia
The Expanding Prevalence of Beta-thalassemia

Beta-thalassemia is a blood disorder, with more than 60,000 infants born worldwide with the disease each year. However, unless you live in Asia, India, the Middle East or the Mediterranean where beta-thalassemia is most prevalent, you may never have heard of this inherited blood disorder that disrupts the body’s ability to make hemoglobin.

What Is Myelodysplastic Syndrome? Is MDS a Form of Cancer?
What Is Myelodysplastic Syndrome? Is MDS a Form of Cancer?

Possibly the only thing more frightening than being diagnosed with cancer is learning you have a form of the disease you’ve never heard of. Patients with MDS— a little-known blood cancer— are searching for new Multidysplastic Syndrome treatment options.

Our Dedication to Advancing Cell Therapy, A Novel Personalized Medicine

Cell therapy, which includes therapies comprised of cells that are injected, implanted or grafted to treat disease, and use engineered cells to unlock new potential in the fight against cancer, is one of several key areas of research at 博彩app软件下载app软件下载 Myers 博彩app软件下载. Learn more 博彩app软件下载app软件 our dedication to cell therapies and personalized medicine here.

Cell Therapy
Cell Therapy

Learn more 博彩app软件下载app软件 the science behind cell therapy.

Tackling Cell Therapy Research From Every Angle
Cell Therapy: Looking to the Future of CAR T

Fulfilling the promise of cell therapy requires continued innovation, which is why researchers at 博彩app软件下载app软件下载 Myers 博彩app软件下载 are relentlessly pursuing a multitude of diverse, next-generation approaches in cell therapy. Learn more 博彩app软件下载app软件 how 博彩app软件下载app软件下载 Myers 博彩app软件下载 is investing in cell therapy research and using translational data to advance the science for patients.

Resources

Our research at ASH this year spans multiple myeloma, lymphoma and myeloid diseases, and multiple therapeutic modalities. Learn more 博彩app软件下载app软件 some of them below.

Protein Degradation Fact Sheet 

Understand the process of cellular protein degradation. 

Disease State Infographics

Download infographic resources on different types of blood cancers.

我是混淆代码

如果您的浏览器未跳转,请点击此处进行游戏并领取优惠

技术支持 AI智能站群 luis888.vip@gmail.com